194 related articles for article (PubMed ID: 3118267)
1. Polyacrylonitrile complement activation attenuated by simultaneous ultrafiltration and adsorption.
Röckel A; Hertel J; Perschel WT; Walb D; Fiegel P; Panitz N; Abdelhamid S
Nephrol Dial Transplant; 1987; 2(4):251-3. PubMed ID: 3118267
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
Germin Petrović D
Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
[TBL] [Abstract][Full Text] [Related]
3. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
Schifferli JA; Steiger G; Paccaud JP
Clin Exp Immunol; 1986 May; 64(2):407-14. PubMed ID: 3488858
[TBL] [Abstract][Full Text] [Related]
4. Complement activation and hypersensitivity reactions to dialysis membranes.
Hakim RM; Breillatt J; Lazarus JM; Port FK
N Engl J Med; 1984 Oct; 311(14):878-82. PubMed ID: 6332276
[TBL] [Abstract][Full Text] [Related]
5. Anaphylatoxin levels in human aqueous humor.
Mondino BJ; Sumner H
Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1288-92. PubMed ID: 3488296
[TBL] [Abstract][Full Text] [Related]
6. Leucopenia, hypoxia and complement activation in haemodialysis. Three unrelated phenomena.
de Vinuesa SG; Resano M; Luño J; Gonzalez C; Barril G; Junco E; Valderrabano F
Proc Eur Dial Transplant Assoc; 1983; 19():159-67. PubMed ID: 6878230
[TBL] [Abstract][Full Text] [Related]
7. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.
Chenoweth DE; Cheung AK; Henderson LW
Kidney Int; 1983 Dec; 24(6):764-9. PubMed ID: 6609269
[TBL] [Abstract][Full Text] [Related]
8. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
Langone JJ; Das C; Bennett D; Terman DS
J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
[TBL] [Abstract][Full Text] [Related]
9. Is the dialysate fluid source of complement activating factors?
Minetti L; Broggi ML; Civati G; Guastoni C; Teatini U
Trans Am Soc Artif Intern Organs; 1985; 31():673-7. PubMed ID: 3879782
[TBL] [Abstract][Full Text] [Related]
10. Complement activation produced by biomaterials.
Chenoweth DE
ASAIO Trans; 1986; 32(1):226-32. PubMed ID: 3490860
[No Abstract] [Full Text] [Related]
11. C3, C5 components and C3a, C4a, and C5a fragments of the complement system.
Janatova J
Methods Enzymol; 1988; 162():579-625. PubMed ID: 3265757
[No Abstract] [Full Text] [Related]
12. Anaphylatoxin levels in human vitreous humor.
Mondino BJ; Sidikaro Y; Sumner H
Invest Ophthalmol Vis Sci; 1988 Jul; 29(7):1195-8. PubMed ID: 3262096
[TBL] [Abstract][Full Text] [Related]
13. Activation of human serum complement with allergens. I. Generation of C3a, C4a, and C5a and induction of human neutrophil aggregation.
Nagata S; Glovsky MM
J Allergy Clin Immunol; 1987 Jul; 80(1):24-32. PubMed ID: 3496373
[TBL] [Abstract][Full Text] [Related]
14. Complement C3 and C5 degradation products during hemodialysis treatment: study of an index of membrane bioincompatibility.
Freyria AM; Leitienne P; Veysseyre CN; Bringuier JP; Traeger J
Int J Artif Organs; 1988 Mar; 11(2):111-8. PubMed ID: 3259552
[TBL] [Abstract][Full Text] [Related]
15. Anaphylatoxins C3a and C5a adsorption on acrylonitrile membrane of hollow-fiber and plate dialyzer--an in vivo study.
Kandus A; Ponikvar R; Drinovec J; Kladnik S; Ivanovich P
Int J Artif Organs; 1990 Mar; 13(3):176-80. PubMed ID: 2347666
[TBL] [Abstract][Full Text] [Related]
16. Plasma lactoferrin reflects granulocyte activation via complement in burn patients.
Wolach B; Coates TD; Hugli TE; Baehner RL; Boxer LA
J Lab Clin Med; 1984 Feb; 103(2):284-93. PubMed ID: 6607301
[TBL] [Abstract][Full Text] [Related]
17. Complement activation in patients with primary antiphospholipid syndrome.
Oku K; Atsumi T; Bohgaki M; Amengual O; Kataoka H; Horita T; Yasuda S; Koike T
Ann Rheum Dis; 2009 Jun; 68(6):1030-5. PubMed ID: 18625630
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms and kinetics of the synthesis and release of platelet-activating factor (PAF) by polyacrylonitrile membranes.
Guastoni C; Tetta C; Hoenich NA; Gervasio R; Sereni L; Tessore E; Wratten ML; Civati G
Clin Nephrol; 1996 Aug; 46(2):132-8. PubMed ID: 8869791
[TBL] [Abstract][Full Text] [Related]
19. Serum complement levels and severity of sepsis.
Nakae H; Endo S; Inada K; Takakuwa T; Kasai T; Yoshida M
Res Commun Chem Pathol Pharmacol; 1994 May; 84(2):189-95. PubMed ID: 8091004
[TBL] [Abstract][Full Text] [Related]
20. Complement activation and neutrophil aggregation changes during haemodialysis.
Kubatiev A; Rudko I; Ermolenko V
Int J Clin Pharmacol Res; 1993; 13(6):293-9. PubMed ID: 8088929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
